about
Combined liver resection and reconstruction of the supra-renal vena cava: the Paul Brousse experience.Ischaemic preconditioning of the graft in adult living related right lobe liver transplantation: impact on ischaemia-reperfusion injury and clinical relevance.Regenerative nodular hyperplasia of the liver related to chemotherapy: impact on outcome of liver surgery for colorectal metastasesHepatectomy for hepatocellular carcinoma larger than 10 cm: preoperative risk stratification to prevent futile surgeryPlace of the liver biopsy in liver transplantation.Mitochondrial roles and cytoprotection in chronic liver injuryLiver biopsy interpretation for causes of late liver allograft dysfunction.Evidence of intermetastatic heterogeneity for pathological response and genetic mutations within colorectal liver metastases following preoperative chemotherapy.Quality of life 10 years after liver transplantation: The impact of graft histology.Recurrence of autoimmune disease, primary sclerosing cholangitis, primary biliary cirrhosis, and autoimmune hepatitis after liver transplantation.Autophagy is induced by ischemic preconditioning in human livers formerly treated by chemotherapy to limit necrosis.Significance of isolated hepatic veno-occlusive disease/sinusoidal obstruction syndrome after liver transplantation.Histologic findings predictive of a diagnosis of de novo autoimmune hepatitis after liver transplantation in adults.Primary non-functioning neuroendocrine tumor of the extrahepatic bile duct.Ischemic Postconditioning of the Liver Graft in Adult Liver Transplantation.Hepatitis B virus pregenomic RNA in hepatocellular carcinoma: A nosological and prognostic determinant.Herpes simplex virus-associated acute liver failure: a difficult diagnosis with a poor prognosis.Influence of Donor and Recipient CYP3A4, CYP3A5, and ABCB1 Genotypes on Clinical Outcomes and Nephrotoxicity in Liver Transplant Recipients.Efficacy of Sofosbuvir and Daclatasvir in Patients With Fibrosing Cholestatic Hepatitis C After Liver Transplantation.Therapy with boceprevir or telaprevir in HIV/hepatitis C virus co-infected patients to treat recurrence of hepatitis C virus infection after liver transplantation.Hepatitis E infection in patients with severe acute alcoholic hepatitis.Successful anti-hepatitis C virus therapy with telaprevir in an HIV/hepatitis C virus co-infected patient with a severe recurrence of hepatitis C virus infection on the liver graft.Acute liver failure due to antitubercular therapy: Strategy for antitubercular treatment before and after liver transplantation.Plasma cell hepatitis in liver allografts: Variant of rejection or autoimmune hepatitis?Escape hepatitis B virus mutations in recipients of antibody to hepatitis B core antigen-positive liver grafts receiving hepatitis B immunoglobulins.Immunoproteomic analysis of potentially severe non-graft-versus-host disease hepatitis after allogenic bone marrow transplantation.Combined effects of fasting and alanine on liver function recovery after cold ischemia.Follicular dendritic cell tumor of the mediastinum: expression of fractalkine and SDF-1alpha as mast cell chemoattractants.Beneficial effect of pentoxifylline on microvesicular steatotic livers submitted to a prolonged cold ischemia.Lengthy follow-up after liver transplantation for nodular regenerative hyperplasia in human immunodeficiency virus-infected patients: does the disease recur?Long-term follow-up of liver transplanted HIV/hepatitis B virus coinfected patients: perfect control of hepatitis B virus replication and absence of mitochondrial toxicity.Hepatitis C virus therapy in liver transplant recipients: response predictors, effect on fibrosis progression, and importance of the initial stage of fibrosis.A new indication for liver transplantation: nodular regenerative hyperplasia in human immunodeficiency virus-infected patients.Hepatocellular carcinoma is associated with an increased risk of hepatitis B virus recurrence after liver transplantation.Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus.Hepatitis C virus viral recurrence and liver mitochondrial damage after liver transplantation in HIV-HCV co-infected patients.Donor age influences 10-year liver graft histology independently of hepatitis C virus infection.Reply to: "Frequent plasma cell hepatitis during telaprevir-based triple therapy for hepatitis C after liver transplantation".Twenty-year protocol liver biopsies: Invasive but useful for the management of liver recipients.Exploration of global gene expression in human liver steatosis by high-density oligonucleotide microarray.
P50
Q33247711-FB740677-DD0E-407B-9CD3-467A7E45DBB4Q34538821-2B8AF018-C6C7-4C2C-BBC4-0700EB9714BFQ34601615-5000E1B9-2AC8-467F-9D06-7AB74FCAD5D6Q35761108-9B2E66D7-CC6B-46A0-A86A-B53C65595071Q35974721-5F1D2706-D7D8-489F-AE33-0D9AF3DCFF39Q36055801-69F2C5B3-B286-4852-8E76-D1EE77E459D2Q36548482-327FD752-4410-43CD-9436-0AE46C19C0FDQ37225348-0A3D1DF9-15FD-444B-9FC3-62837BF0060CQ37522602-E11E1A5B-CF3F-4AC8-90B5-A1C1CBA8EB2BQ37624569-022D1610-DD94-4CB7-8557-3E48F02F732DQ37653923-7295D171-C597-4B84-A593-4D212DD8CEAEQ37847112-9D35A94A-C6FC-494F-B09F-12DD6CD0F18DQ38132027-49401E31-8E8F-4E34-96CE-EC65F6D927D7Q38820791-ACF59DAC-3650-48EF-B5F8-A497AF2395B6Q39020041-C8AD40ED-C2FD-424F-AFFD-60A9C7ADC44FQ40085341-D0A2EDEE-76A2-4D99-8355-89FE21EB1F00Q40492767-59D522F3-ABB6-48CF-BF0D-9FEB7345428CQ40571943-7108DE0A-F180-4F62-ADB0-86A74A96DB7BQ40868665-01E16B8D-D1FB-469A-A024-3BF84767B4E0Q41667650-186D555F-7201-42E0-AE42-CE1AA0708F9CQ42214033-C2636E45-5CB2-4FAB-9030-70DDFE668759Q42277139-D58E383B-CD7C-4D9A-B059-8DEB800C5035Q42873894-11881484-9AD2-42FF-A813-B682B8DE5E23Q42978721-6BE83B8E-E060-447C-9753-C8978C1B5FA4Q43003664-AD3243B6-3A69-4266-AB28-FBF58E22D782Q43471150-E2E0382A-D6F0-495A-ABC9-EE7C3E10645FQ43949041-D7E12CBB-DACD-4D89-9204-42F999A77975Q44432002-E00D6BE4-F602-40D7-BB74-8B6B37AD2B75Q44514922-3912B629-07A6-4C6E-9CEB-CCB4413F1830Q45348710-4841D04A-E7BD-4E13-AA9F-EC3CBF9498C5Q45384830-01F41C8B-00B3-4F27-A264-AA74C0FEA130Q45388486-1A622DC8-1A6C-4C0E-A907-61D0FE1200CCQ45392493-FA15910E-D167-4C7F-9361-689EA033F9A7Q45395704-520F59BC-2576-4FEA-A393-FFC49D517345Q45398475-B0055883-10BF-4A1F-9559-B2A7F703E72BQ45511696-26B42F03-B343-4E58-9BEA-48473BAA738CQ45595201-DEB1FD9B-1FE6-4818-9CF8-C82CEF8DD36BQ45891688-C5A515F6-F136-449F-8F9B-14B5FD26AB83Q46266466-F2152839-28F4-4A0A-BB17-8ADFB12FA1AAQ46848211-3D6C20CC-F619-4C3E-992A-BD1CF601CD0A
P50
name
Mylène Sebagh
@en
type
label
Mylène Sebagh
@en
prefLabel
Mylène Sebagh
@en